Lioresal Intrathecal (baclofen): Reviews and patient testimonials
Back to the list of medications
Medication indications
Lioresal Intrathecal
Lioresal Intrathecal is indicated in patients with severe chronic spasticity of spinal or cerebral origin (associated with injury, multiple sclerosis, cerebral palsy) who are unresponsive to oral baclofen or other orally administered antispastic agents and/or those patients who experience unacceptable side-effects at effective oral doses.
In patients with spasticity due to head injury a delay of at least one year before treatment with Lioresal Intrathecal is recommended, to allow the symptoms of spasticity to stabilise.
Lioresal Intrathecal may be considered as an alternative to ablative neurosurgical procedures.
Paediatric population
Lioresal Intrathecal is indicated in patients aged 4 to <18 years with severe chronic spasticity of cerebral origin or of spinal origin (associated with injury, multiple sclerosis, or other spinal cord diseases) who are unresponsive to orally administered antispastics (including oral baclofen) and/or who experience unacceptable side effects at effective oral doses.
Molecule: baclofen
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.